United States · FDA National Drug Code directory

Haloperidol decanoate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70710-1461_b06b16a2-177a-4bd6-b1fa-80d1be6acfb8
Product NDC: 70710-1461
Form: INJECTION
Composition / generic term: Haloperidol decanoate
Labeler: Zydus Pharmaceuticals USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20191114
Source listing expiry: 20271231

Source-listed ingredients

HALOPERIDOL DECANOATE — 50 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

10 VIAL, SINGLE-DOSE in 1 CARTON (70710-1461-6) / 1 mL in 1 VIAL, SINGLE-DOSE · 70710-1461-6
3 VIAL, SINGLE-DOSE in 1 CARTON (70710-1461-9) / 1 mL in 1 VIAL, SINGLE-DOSE · 70710-1461-9

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →